Search Records

Learn how to keep pets and livestock, as well as yourself, safe during the COVID-19 pandemic.

If you have travelled recently by plane, train or cruise ship, use this Government of Canada tool to find out if you might have been exposed to COVID-19.

The guidance identifies core personal and community-based public health measures to mitigate the transmission of coronavirus disease (COVID-19).

This tool will assist individuals, groups, or organizations, representing diverse groups based on gender, ethnicity/culture, and other socio-economic and demographic factors, in considering risks related to planning, organizing or operating gatherings/events during the coronavirus disease...

The table below lists the clinical trials authorized by Health Canada for COVID-19-related medical devices.

The Government of Canada and the Canadian Pain Task Force (CPTF) recognize Canadians living with chronic pain need additional supports during COVID-19. The following list of supportive resources was assembled in collaboration with stakeholders and may be used by you and your partners in care to...

To assist with Canada’s response to COVID-19, the Honourable Patty Hajdu, Minister of Health, announced that she has signed an Interim Order to allow expedited access to COVID-19-related medical devices for use by healthcare providers, including diagnostic test kits.

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the...

"Health Canada appreciates the critical role health professionals in Canada play in identifying, reporting and managing potential cases of COVID-19 and recognizes the pressures a surge in people requiring medical care can cause on facilities. In light of the current situation, Health Canada is...

In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.